Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate how teriparatide or zoledronic acid affects the
bone of postmenopausal osteoporotic women after 6 months of treatment as determined by a bone
biopsy sample taken from the iliac crest (upper part of the pelvis). After completing 12
months of treatment all participants are eligible to participate in an additional 12-month
open label extension.